Skip to main content
SpringerLink
Log in

Concentrations of Cd, Co, Cu, Fe, Mn, Rb, V, and Zn in formalin-fixed brain tissue in amyotrophic lateral sclerosis and parkinsonism-dementia complex of guam determined by high-resolution ICP-MS

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Amyotrophic lateral sclerosis (ALS) and parkinsonism-dementia complex (PDC) are neurodegenerative disorders that occurred with extremely high frequency among the native population on Guam, especially in the 1950s and 1960s, but have substantially declined over the last half-century. The etiology of these diseases is unknown, but the most plausible hypothesis centers on imbalances in essential and toxic metals. We have determined the concentrations of Cd, Co, Cu, Fe, Mn, Rb, V, and Zn in formalin-fixed brain tissue collected during the period 1979–1983 from eight Guamanian patients with ALS, four with PDC, and five control subjects using high-resolution inductively coupled plasma-mass spectrometry. The concentrations of Cd are markedly and significantly elevated both in gray and white matter in ALS, but not in PDC patients. The concentrations of Zn are elevated for both patient groups, in both gray and white matter, but only the difference in gray matter for PDC is significant. For the other metals, no significant differences are found.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. L. T. Kurland and D. W. Mulder, Epidemiologic investigations of amyotrophic lateral sclerosis. 1. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations, Neurology 4, 355–378, 438–448 (1954).

    PubMed  CAS  Google Scholar 

  2. A. Hirano, L. T. Kurland, R. S. Krooth, and S. Lessell, Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features, Brain 84, 642–661 (1961).

    Article  PubMed  CAS  Google Scholar 

  3. J. A. Brody and L. T. Kurland, Amyotrophic lateral sclerosis and parkinsonism-dementia in Guam, in Tropical Neurology, J. D. Spillane, ed., Oxford University Press, New York, pp. 355–375 (1973).

    Google Scholar 

  4. D. C. Gajdusek, Motor-neuron disease in natives of New Guinea, N. Engl. J. Med. 268, 474–476 (1963).

    Article  PubMed  CAS  Google Scholar 

  5. K. Kimura, Y. Yase, Y. Higashi, et al., Epidemiological and geomedical studies on amytrophic lateral sclerosis, Dis. Nerv. Syst. 24, 155–159 (1963).

    Google Scholar 

  6. A. Hirano, N. Malamud, and L. T. Kurland, Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features, Brain 84, 662–679 (1961).

    Article  PubMed  CAS  Google Scholar 

  7. V. Buée-Scherrer, L. Buée, P. R. Hof, et al., Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: immunochemical characterization of tau proteins, Am. J. Pathol. 146, 924–932 (1995).

    PubMed  Google Scholar 

  8. M. Mawal-Dewan, M. L. Schmidt, B. Balin, D. P. Perl, V. M.-Y. Lee, and J. Q. Trojanowski, Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex, J. Neuropathol. Exp. Neurol. 55, 1051–1059 (1996).

    PubMed  CAS  Google Scholar 

  9. R. M. Garruto, Pacific paradigms of environmentally induced neurological disorders: clinical, epidemiological and molecular perspectives, Neurotoxicology 12, 347–377 (1991).

    PubMed  CAS  Google Scholar 

  10. J. E. Bailey-Wilson, C. C. Plato, R. C. Elston, and R. M. Garruto, Potential role of an additive genetic component in the cause of amyotrophic lateral sclerosis and parkinsonism-dementia in the western Pacific, Am. J. Med. Genet. 45, 68–76 (1993).

    Article  PubMed  CAS  Google Scholar 

  11. P. Poorkaj, D. Tsuang, E. Wijsman, et al., TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam, Arch. Neurol. 58, 1871–1878 (2001).

    Article  PubMed  CAS  Google Scholar 

  12. C. C. Plato, D. Galasko, R. M. Garruto, et al., ALS and PDC of Guam: forty-year follow-up, Neurology 58, 765–773 (2002).

    PubMed  CAS  Google Scholar 

  13. R. M. Garruto, R. Yanagihara, and D. C. Gajdusek, Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, Neurology 35, 193–198 (1985).

    PubMed  CAS  Google Scholar 

  14. P. Rodgers-Johnson, R. M. Garruto, R. Yanagihara, K.-M. Chen, D. C. Gajdusek, and C. J. Gibbs, Jr., Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30-year evaluation of clinical and neuropathologic trends, Neurology 36, 7–13 (1986).

    PubMed  CAS  Google Scholar 

  15. D. Galasko, D. P. Salmon, U.-K. Craig, L. J. Thal, G. Schellenberg, and W. Wiederholt, Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997–2000, Neurology 58, 90–97 (2002).

    PubMed  CAS  Google Scholar 

  16. C. C. Plato, R. M. Garruto, D. Galasko, et al., Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: Changing incidence rates during the past 60 years, Am. J. Epidemiol. 157, 149–157 (2003).

    Article  PubMed  Google Scholar 

  17. P. S. Spencer, P. B. Nunn, J. Hugon, et al., Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin, Science 237, 517–522 (1987).

    Article  PubMed  CAS  Google Scholar 

  18. D. C. Gajdusek, Cycad toxicity not the cause of high-incidence amyotrophic lateral sclerosis/parkinsonism-dementia on Guam, Kii peninsula of Japan, or in West New Guinea, in Amyotrophic Lateral Sclerosis: Concepts in Pathogenesis and Etiology, A. J. Hudson, ed., University of Toronto Press, Toronto, pp. 317–325 (1990).

    Google Scholar 

  19. M. W. Duncan, J. C. Steele, I. J. Kopin, and S. P. Markey, 2-Amino-3(methylamino)-propanoic acid (BMAA) in cycad flour: An unlikely cause of amyotrophic lateral sclerosis and parkinsonism dementia of Guam, Neurology 40, 767–772 (1990).

    PubMed  CAS  Google Scholar 

  20. F. Esclaire, G. Kisby, P. Spencer, J. Milne, M. Lesort, and J. Hugon, The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity, Exp. Neurol. 155, 11–21 (1999).

    Article  PubMed  CAS  Google Scholar 

  21. I. Khabazian, J. S. Bains, D. E. Williams, et al., Isolation of various forms of sterol β-d-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex, J. Neurochem. 82, 516–528 (2002).

    Article  PubMed  CAS  Google Scholar 

  22. D. C. Crapper McLachlan, C. D. McLachlan, B. Krishnan, S. S. Krishnan, A. J. Dalton, and J. C. Steele, Aluminium and calcium in soil and food from Guam, Palau and Jamaica: implications for amyotrophic lateral sclerosis and parkinsonism-dementia syndromes of Guam, Environ. Geochem. Health 11, 45–53 (1989).

    Article  Google Scholar 

  23. Y. Yase, The pathogenesis of amyotrophic lateral sclerosis, Lancet 2, 292–296 (1972).

    Article  PubMed  CAS  Google Scholar 

  24. F. Yoshimasu, M. Yasui, Y. Yase, et al., Studies on amyotrophic lateral sclerosis by neutron activation analysis. 2. Comparative study of analytical results on Guam PD, Japanese ALS and Alzheimer disease cases, Folia Psychiatr. Neurol. Jpn. 34, 75–82 (1980).

    PubMed  CAS  Google Scholar 

  25. F. Yoshimasu, M. Yasui, Y. Yase, et al., Studies on amyotrophic lateral sclerosis by neutron activation analysis. 3. Systematic analysis of metals on Guamanian ALS and PD cases, Folia Psychiatr. Neurol. Jpn. 36, 173–180 (1982).

    PubMed  CAS  Google Scholar 

  26. R. D. Traub, T. C. Rains, R. M. Garruto, D. C. Gajdusek, and C. J. Gibbs, Jr., Brain destruction alone does not elevate brain aluminum, Neurology 31, 986–990 (1981).

    PubMed  CAS  Google Scholar 

  27. M. Yasui, K. Ota, and R. M. Garruto, Concentrations of zinc and iron in the brains of Guamanian patients with amyotrophic lateral sclerosis and parkinsonism-dementia, Neurotoxicology 14, 445–450 (1993).

    PubMed  CAS  Google Scholar 

  28. F. Yoshimasu, Y. Uebayashi, Y. Yase, S. Iwata, and K. Sasajima, Studies on amyotrophic lateral sclerosis by neutron activation analysis, Folia Psychiatr. Neurol. Jpn. 30, 49–55 (1976).

    PubMed  CAS  Google Scholar 

  29. M. Yasui, Y. Yase, K. Ota, and R. M. Garruto, Aluminum deposition in the central nervous system of patients with amyotrophic lateral sclerosis from the Kii peninsula of Japan, Neurotoxicology 12, 615–620 (1991).

    PubMed  CAS  Google Scholar 

  30. M. Yasui, Y. Yase, T. Kihira, K. Adachi, and Y. Suzuki, Magnesium and calcium contents in CNS tissues of amyotrophic lateral sclerosis patients from the Kii peninsula, Japan, Eur. Neurol. 32, 95–98 (1992).

    PubMed  CAS  Google Scholar 

  31. H. Vanhoe, A review of the capabilities of ICP-MS for trace element analysis in body fluids and tissues, J. Trace Elements Electrolytes Health Dis. 7, 131–139 (1993).

    CAS  Google Scholar 

  32. J. Begerow, M. Turfeld, and L. Dunemann, New horizons in human biomonitoring of environmentally and occupationally relevant metals—sector-field ICP-MS versus electrothermal AAS, J. Anal. Atomic Spectrom. 15, 347–352 (2000).

    Article  CAS  Google Scholar 

  33. M. Yasui, M. J. Strong, K. Ota, and M. A. Verity, eds., Mineral and Metal Neurotoxicology, CRC, Boca Raton, FL (1997).

    Google Scholar 

  34. F. H. Anderson, E. P. Richardson, Jr., H. Okazaki, and J. A. Brody, Neurofibrillary degeneration on Guam: frequency in Chamorros and non-Chamorros with no known neurological disease, Brain 102, 65–77 (1979).

    Article  PubMed  CAS  Google Scholar 

  35. V. J. Bush, T. P. Moyer, K. P. Batts, and J. E. Parisi, Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues, Clin. Chem. 41, 284–294 (1995).

    PubMed  CAS  Google Scholar 

  36. R. D. Meldrum, Erroneous aluminum and cobalt tissue concentrations from using formalin, J. Biomed. Mater. Res. 57, 59–62 (2001).

    Article  PubMed  CAS  Google Scholar 

  37. M. T. Rajan, K. S. J. Rao, B. M. Mamatha, et al., Quantification of trace elements in normal human brain by inductively coupled plasma atomic emission spectrometry, J. Neurol. Sci. 146, 153–166 (1997).

    Article  PubMed  CAS  Google Scholar 

  38. L. Zecca, R. Pietra, C. Goj, C. Mecacci, D. Radice, and E. Sabbioni, Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain, J. Neurochem. 62, 1097–1101 (1994).

    Article  PubMed  CAS  Google Scholar 

  39. A. E. Panayi, N. M. Spyrou, B. S. Iversen, M. A. White, and P. Part, Determination of cadmium and zinc in Alzheimer’s brain tissue using inductively coupled plasma mass spectrometry, J. Neurol. Sci. 195, 1–10 (2002).

    Article  PubMed  CAS  Google Scholar 

  40. J. E. Ahlskog, S. C. Waring, L. T. Kurland, et al., Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis, Neurology 45, 1340–1344 (1995).

    PubMed  CAS  Google Scholar 

  41. N. M. Spyrou and J. D. Stedman, Cadmium concentrations in the brains of Alzheimer cases, Trans. Am. Nucl. Soc. 74, 6–7 (1996).

    Google Scholar 

  42. R. Pamphlett, R. McQuilty, and K. Zarkos, Blood levels of toxic and essential metals in motor neuron disease, Neurotoxicology 22, 401–410 (2001).

    Article  PubMed  CAS  Google Scholar 

  43. M. Vinceti, D. Guidetti, M. Bergomi, et al., Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis, Ital. J. Neurol. Sci. 18, 87–92 (1997).

    Article  PubMed  CAS  Google Scholar 

  44. P. A. E. S. Smitt, H. van Beek, A.-J. Baars, et al., Increased metallothionein in the liver and kidney of patients with amyotrophic lateral sclerosis, Arch. Neurol. 49, 721–724 (1992).

    Google Scholar 

  45. B. Arvidson, A review of axonal transport of metals, Toxicology 88, 1–14 (1994).

    Article  PubMed  CAS  Google Scholar 

  46. W. R. Markesbery, W. D. Ehmann, J. M. Candy, et al., Neutron activation analysis of trace elements in motor neuron disease spinal cord, Neurodegeneration 4, 383–390 (1995).

    Article  PubMed  CAS  Google Scholar 

  47. Z. X. Zhang, D. W. Anderson, N. Mantel, and G. C. Román, Motor neuron disease on Guam: geographic and familial occurrence, 1956–85, Acta Neurol. Scand. 94, 51–59 (1996).

    Article  PubMed  CAS  Google Scholar 

  48. J. D. Mitchell, I. A. Harris, B. W. East, and B. Pantland, Trace elements in cerebrospinal fluid in motor neurone disease, Br. Med. J. 288, 1791–1792 (1984).

    CAS  Google Scholar 

  49. J. D. Mitchell, B. W. East, I. A. Harris, and B. Pentland, Manganese, selenium and other trace elements in spinal cord, liver and bone in motor neurone disease, Eur. Neurol. 31, 7–11 (1991).

    PubMed  CAS  Google Scholar 

  50. S. E. Arnold and A. Kumar, Reversible dementias, Med. Clin. North Am. 77, 215–230 (1993).

    PubMed  CAS  Google Scholar 

  51. R. J. Uitti, A. H. Rajput, B. Rozdilsky, and W. K. Yuen, Regional distribution of metals in human brain, Clin. Invest. Med. 10, 10–13 (1987).

    PubMed  CAS  Google Scholar 

  52. M. A. Deibel, W. D. Ehmann, and W. R. Markesbery, Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress, J. Neurol. Sci. 143, 137–142 (1996).

    Article  PubMed  CAS  Google Scholar 

  53. C. R. Cornett, W. R. Markesbery, and W. D. Ehmann, Imbalances of trace elements related to oxidative damage in Alzheimer’s disease brain, Neurotoxicology 19, 339–345 (1998).

    PubMed  CAS  Google Scholar 

  54. R. J. Uitti, A. H. Rajput, B. Rozdilsky, M. Bickis, T. Wollin, and W. K. Yuen, Regional metal concentrations in Parkinson’s disease, other chronic neurological diseases, and control brains, Can. J. Neurol. Sci. 16, 310–314 (1989).

    PubMed  CAS  Google Scholar 

  55. D. Berg, M. Gerlach, M. B. H. Youdim, et al., Brain iron pathways and their relevance to Parkinson’s disease, J. Neurochem. 79, 225–236 (2001).

    Article  PubMed  CAS  Google Scholar 

  56. K. J. Thompson, S. Shoham, and J. R. Connor, Iron and neurodegenerative disorders, Brain Res. Bull. 55, 155–164 (2001).

    Article  PubMed  CAS  Google Scholar 

  57. J. D. Mitchell, Amyotrophic lateral sclerosis: toxins and environment, Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 235–250 (2000).

    Article  PubMed  CAS  Google Scholar 

  58. I. Mena, O. Marin, S. Fuenzalida, and G. C. Cotzias, Chronic manganese poisoning: clinical picture and manganese turnover, Neurology 17, 128–136 (1967).

    PubMed  CAS  Google Scholar 

  59. D. B. Calne, N.-S. Chu, C.-C. Huang, C.-S. Lu, and W. Olanow, Manganism and idiopathic parkinsonism: Similarities and differences, Neurology 44, 1583–1586 (1994).

    PubMed  CAS  Google Scholar 

  60. R. A. K. Srivastava and J. C. Jain, Scavenger receptor class B type I expression and elemental analysis in cerebellum and parietal cortex regions of the Alzheimer’s disease brain, J. Nuerol. Sci. 196, 45–52 (2002).

    Article  CAS  Google Scholar 

  61. M. Yukawa, M. Suzuki-Yasumoto, K. Amano, and M. Terai, Distribution of trace elements in the human body determined by neutron activation analysis, Arch. Environ. Health 35, 36–44 (1980).

    PubMed  CAS  Google Scholar 

  62. S. Yoshida, Y. Yase, S. Iwata, Y. Mizumoto, K.-M. Chen, and D. C. Gajdusek, Comparative trace-elemental study on amyotrophic lateral sclerosis (ALS) and parkinsonism-dementia (PD) in the Kii peninsula of Japan and Guam, Wakayama Med. Rep. 30, 41–53 (1988).

    Google Scholar 

  63. D. T. Dexter, P. Jenner, A. H. V. Schapira, and C. D. Marsden, Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia, Ann. Neurol. 32, S94–S100 (1992).

    Article  PubMed  CAS  Google Scholar 

  64. D. Wenstrup, W. D. Ehmann, and W. R. Markesbery, Trace element imbalances in isolated subcellular fractions of Alzheimer’s disease brains, Brain Res. 533, 125–131 (1990).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, Norwegian University of Science and Technology, Trondheim, Norway

    Kristin Gellein, Torill E. Sjøbakk & Trond Peder Flaten

  2. Department of Clinical Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway

    Tore Syversen

  3. Departments of Anthropology and Biological Sciences, State University of New York, Binghamton, NY

    Ralph M. Garruto

  4. National Institutes of Health, Bethesda, MD

    Ralph M. Garruto

Authors
  1. Kristin Gellein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ralph M. Garruto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tore Syversen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Torill E. Sjøbakk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Trond Peder Flaten
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gellein, K., Garruto, R.M., Syversen, T. et al. Concentrations of Cd, Co, Cu, Fe, Mn, Rb, V, and Zn in formalin-fixed brain tissue in amyotrophic lateral sclerosis and parkinsonism-dementia complex of guam determined by high-resolution ICP-MS. Biol Trace Elem Res 96, 39–60 (2003). https://doi.org/10.1385/BTER:96:1-3:39

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/BTER:96:1-3:39

Index Entries

Search

Navigation